$22.220
+0.851 (+3.83%)At close
ATTO Comparative Benchmarking
In the context of the broader market, ATTO competes directly with industry leaders such as IVA and DSGN. With a market capitalization of $923.40M, it holds a significant position in the sector. When comparing efficiency, ATTO's gross margin of N/A stands against IVA's 100.00% and DSGN's N/A. Such benchmarking helps identify whether Attovia Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Attovia Therapeutics Inc Financial Performance
Attovia has shown a gross margin of 0% for Q1 2026, indicating no revenue generation yet, but it has a strong current ratio of 13.94, suggesting good liquidity. The forward P/E ratio of 4.81 indicates potential for future earnings growth.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.